CAS 2192281-54-0

Fórmula: C63H92IN11O23

InChI: InChI=1S/C63H92IN11O23/c64-42-34-41(18-21-49(42)76)36-46(67-52(79)22-20-48(62(96)97)75-32-30-73(38-55(84)85)28-26-72(37-54(82)83)27-29-74(31-33-75)39-56(86)87)57(88)69-47(35-40-12-4-3-5-13-40)58(89)68-43(59(90)91)14-8-10-24-65-50(77)16-6-1-2-7-17-51(78)66-25-11-9-15-44(60(92)93)70-63(98)71-45(61(94)95)19-23-53(80)81/h3-5,12-13,18,21,34,43-48,76H,1-2,6-11,14-17,19-20,22-33,35-39H2,(H,65,77)(H,66,78)(H,67,79)(H,68,89)(H,69,88)(H,80,81)(H,82,83)(H,84,85)(H,86,87)(H,90,91)(H,92,93)(H,94,95)(H,96,97)(H2,70,71,98)/t43-,44+,45+,46-,47-,48-/m1/s1

Clave InChI: HPLNQICCRXHOIA-CIYKLJAQSA-N

SMILES: C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)O)[C@H](CCC(=O)N[C@H](CC2=CC(=C(C=C2)O)I)C(=O)N[C@H](CC3=CC=CC=C3)C(=O)N[C@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)CC(=O)O

PSMA I&T

CAS: 2192281-54-0

PSMA I&T

Fórmula: C₆₃H₉₂IN₁₁O₂₃

Pureza: ≥98%

Peso molecular: 1498.37

Ref: 54-BUP01821

N-[4-Carboxy-1-oxo-4-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]butyl]-3-iodo-D-tyrosyl-D-phenylalanyl-N6-[8-[[(5S)-5-carboxy-5-[[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]amino]pentyl]amino]-1,8-dioxooctyl]-D-lysine

CAS: 2192281-54-0

Pureza: 98.68%

Ref: IN-DA023OEF

PSMA I&T

CAS: 2192281-54-0

(3S,7S,26R,29R,32R)-29-Benzyl-32-(4-hydroxy-3-iodobenzyl)-5,13,20,28,31,34-hexaoxo-37-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)-4,6,12,21,27,30,33-heptaazaheptatriacontane-1,3,7,26,37-pentacarboxylic acid

Fórmula: C₆₃H₉₂IN₁₁O₂₃

Pureza: 98% (acetate)

Peso molecular: 1498.37

Ref: IN-DG01865836

PSMA I&T

CAS: 2192281-54-0

PSMA I&T is a PSMA-targeting radioactive compound that can be used as a diagnostic agent for prostate-specific membrane antigen-targeted therapy.

Fórmula: C₆₃H₉₂IN₁₁O₂₃

Pureza: 98.68%

Forma y color: Solid

Peso molecular: 1498.37

Ref: TM-T78153